• FirefoxUpgrade to the new Firefox »
  •  Dow Up0.13% Nasdaq Up0.70%

    Protalix BioTherapeutics, Inc. (PLX)

    -ASE
    1.83 Down 0.02(1.08%) 4:02PM EST
    Add to Portfolio
    Cash FlowGet Cash Flow for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
    Net Income (27,790) (11,618) (36,529)
    Operating Activities, Cash Flows Provided By or Used In
    Depreciation3,666  3,692  3,631  
    Adjustments To Net Income3,967  7,820  1,385  
    Changes In Accounts Receivables1,904  243  3,891  
    Changes In Liabilities(1,322)2,977  6,147  
    Changes In Inventories(3,918)(3,760)910  
    Changes In Other Operating Activities(7,160)1,281  (3,005)
    Total Cash Flow From Operating Activities (30,653) 635   (23,570)
    Investing Activities, Cash Flows Provided By or Used In
    Capital Expenditures(1,890)(2,068)(5,705)
    Investments -   -   -  
    Other Cash flows from Investing Activities(212)(218)(163)
    Total Cash Flows From Investing Activities (2,102) (2,286) (5,868)
    Financing Activities, Cash Flows Provided By or Used In
    Dividends Paid -   -   -  
    Sale Purchase of Stock112  26,558  20,927  
    Net Borrowings66,780   -   -  
    Other Cash Flows from Financing Activities -   -   -  
    Total Cash Flows From Financing Activities 66,892   26,558   20,927  
    Effect Of Exchange Rate Changes226  127  (388)
    Change In Cash and Cash Equivalents 34,363   25,034   (8,899)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.